STAT June 21, 2024
Elizabeth Cooney

ORLANDO — The United States is at a critical juncture in its efforts to treat chronic diseases, particularly type 2 diabetes, and now has a chance to change the dangerous trajectory it’s currently following, FDA Commissioner Robert Califf said Friday.

“The U.S. is leading the world in technology development, innovation, new gadgets of all kinds, new drugs, you name it,” he said. “These advantages unfortunately are not resulting in superior health and outcomes for the U.S., population, or for most individuals in the U.S.”

Health outcomes as a whole are deteriorating in the U.S., Califf said in his remarks at the American Diabetes Association conference, but he sees one outlier.

“There’s an exception for type 1 diabetes, which I believe...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology, Wearables
Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine
FDA Clears Emerging Brain PET System
STAT+: Applesauce lead contamination could not have been prevented, top FDA official suggests
Trump’s FDA commissioner on regulating AI
FDA creates communication ‘super office’ at CDRH

Share This Article